Detailed dosage guidelines and administration information for Dupixent (dupilumab). Includes dose adjustments, warnings and precautions.
DUPIXENT® (dupilumab) PN Dosage & Administration
How DUPIXENT® (dupilumab) is Taken for EoE
00024591502 - Henry Schein Medical
Dermatology - Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials
How DUPIXENT® (dupilumab) is Taken for EoE
Dupixent Dosage Guide
Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index, HTML
EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis - Agache - 2021 - Allergy - Wiley Online Library
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial - The Lancet
A Clinician's Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis
Transitioning From Immunosuppressants to Dupilumab in Pediatric Atopic Dermatitis
Everything You Need to Know About Dupixent – Cottonique - Allergy-free Apparel
Management of inadequate response and adverse effects to dupilumab in atopic dermatitis - ScienceDirect